KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma
Miriam Analia Meilerman Abuelafia, Patricia Santofimia‐Castaño, Matías Estarás, Daniel Grasso et autres
BackgroundEmerging evidence suggests that chemotherapy can accumulate senescent-like cells within tumor tissues, a phenomenon linked to therapy resistance. The aim of this study is to analyze the senescence-like state of after-treatment persistent cells associated with KRAS mutational status to offer a therapeutic …
fr, us (code pays fourni par la source)
0 citations
CONICET Digital (CONICET)